Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complement-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complement

Published:2020-08 Issue: Volume:124 Page:200-210
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Pedersen Dennis V.,Rösner Thies,Hansen Annette G.,Andersen Kasper R.,Thiel Steffen,Andersen Gregers R.,Valerius Thomas,Laursen Nick S.

Funder

Lundbeck Foundation

Independent Research Fund Denmark, the Novo Nordisk Foundation

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference61 articles.

1. An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae;Agarwal;J. Immunol.,2010

2. Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection;Ali;Proc Natl Acad Sci U S A,2014

3. Optimized E. Coli expression strain LOBSTR eliminates common contaminants from His-tag purification;Andersen;Proteins,2013

4. Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia;Baig;J. Immunol.,2014

5. Complement activation, regulation, and molecular basis for complement-related diseases;Bajic;EMBO J.,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement Factor B (CFB) inhibits the malignant progression of lung adenocarcinoma by downregulating the Ras/MAPK signaling pathway;Archives of Biochemistry and Biophysics;2024-10

2. Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators;Frontiers in Immunology;2024-05-16

3. Complement Factor B (Cfb) Inhibits the Malignant Progression of Lung Adenocarcinoma by Downregulating the Ras/Mapk Signaling Pathway;2024

4. Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies;Journal of Biological Chemistry;2023-08

5. Bispecific Complement Engagers for Targeted Complement Activation;The Journal of Immunology;2023-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3